Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C-Reference-Cited by-同舟云学术

Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C

Published:2001-05 Issue:1-3 Volume:72 Page:217-224
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Kozlowski Antoni,Milton Harris J.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference39 articles.

1. Pathogenesis, natural history, treatment and prevention of hepatitis C;Liang;Ann. Intern. Med.,2000

2. Interferon α-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C;McHutchison;New England J. Med.,1998

3. Poly(ethyleneglycol): Chemistry and Biological Applications,1997

4. A double-blind, multicenter, randomized, parallel dose-comparison study of six regimens of 5 kD, linear peginterferon α-2a compared with roferon-a in patients with chronic hepatitis c;O’Brien,1999

5. Pharmacological properties of five polyethylene glycol conjugates of interferon α-2a;Bailon,1999

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of methioninase for cancer treatment;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07

2. Treatment-induced and Pre-existing Anti-peg Antibodies: Prevalence, Clinical Implications, and Future Perspectives;Journal of Pharmaceutical Sciences;2023-11

3. Effect of Lyophilization on Stability of PEG-Protein Conjugate: A Case Study with Peginterferon alfa-2b;Brazilian Journal of Pharmaceutical Sciences;2023

4. Poly(ethylene glycol) based biomaterials;Handbook of Polymers in Medicine;2023

5. Improved pH stability, heat stability, and functionality of phycocyanin after PEGylation;International Journal of Biological Macromolecules;2022-12